§ 44-109.02. Pre-admission medication management assessment.

Current through October 23, 2012

Within 30 days prior to admission, the ALR shall consult with the prospective resident's healthcare practitioner regarding:

(1) The prospective resident's current medication profile, including a review of nonprescription drugs;

(2) Possible adverse interactions;

(3) Common expected or unexpected side effects; and

(4) The potential that such medications have to act as chemical restraints.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(June 24, 2000, D.C. Law 13-127, § 902, 47 DCR 2647.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 13-127, see notes following § 44-101.01.